TABIA BINNS: Open Payments
NPI 1578248928 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 11 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $15 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| ABBVIE INC. | 1 | $22 |
| Corium, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
Products named: FANAPT, Auvelity, SPRAVATO, VRAYLAR, Azstarys, TRINTELLIX, Qelbree, ABILIFY ASIMTUFII.
Industry payments across MS — which companies pay providers there.
